Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 129.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 137.50
  • 52 Week Low: 96.00
  • Currency: UK Pounds
  • Shares Issued: 104.77m
  • Volume: 5,838
  • Market Cap: £135.16m
  • RiskGrade: 63

Latest ShareCast News

Cello Health sells Pulsar business to Access Intelligence

By Michele Maatouk

Date: Wednesday 02 Oct 2019

(Sharecast News) - Healthcare-focused advisory group Cello Health has sold its social media analytics software business, Pulsar, to Access Intelligence for £4.5m in shares.

Cello Health Regulatory News

Holding(s) in Company 14-Nov-2019 09:30 RNS
Total Voting Rights 13-Nov-2019 17:00 RNS
Holding(s) in Company 07-Oct-2019 13:39 RNS
Total Voting Rights 07-Oct-2019 13:00 RNS
Disposal 02-Oct-2019 08:40 RNS

Cello Health News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 129.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 137.50
52 Week Low 96.00
Volume 5,838
Shares Issued 104.77m
Market Cap £135.16m
RiskGrade 63

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65% below the market average65% below the market average65% below the market average65% below the market average65% below the market average
77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average77.14% above the sector average
Price Trend
46.96% above the market average46.96% above the market average46.96% above the market average46.96% above the market average46.96% above the market average
35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average35.00% above the sector average
Income
8.75% above the market average8.75% above the market average8.75% above the market average8.75% above the market average8.75% above the market average
46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average46.67% above the sector average
Growth
32.67% below the market average32.67% below the market average32.67% below the market average32.67% below the market average32.67% below the market average
41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average41.18% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 15-Nov-2019

Time Volume / Share Price
14:10 58 @ 128.20p
13:29 1,280 @ 128.20p
11:08 4,130 @ 130.00p
10:36 370 @ 129.96p

Cello Health Key Personnel

CEO Mark Scott

Top of Page